The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dhib-Jalbut, S. S.
Right arrow Articles by Cowan, E. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dhib-Jalbut, S. S.
Right arrow Articles by Cowan, E. P.

The Journal of Immunology, Vol 151, Issue 11 6248-6258, Copyright © 1993 by American Association of Immunologists


ARTICLES

Direct evidence that interferon-beta mediates enhanced HLA-class I expression in measles virus-infected cells

SS Dhib-Jalbut and EP Cowan
Department of Neurology, University of Maryland at Baltimore.

Viral infection results in enhancement of HLA-class I expression in a number of cell types, including glial cells, which normally do not express these molecules. This enhancement may occur through a direct interaction between a viral component and the HLA-class I gene or indirectly through virus-induced soluble factors produced by infected cells. These include cytokines such as IFN-gamma, IFN-alpha/beta, and TNF-alpha, known to enhance class I expression. Measles virus (MV) infection of a human glioma cell line (U-105 MG) and of primary human umbilical vein endothelial cells enhances the expression of HLA-class I molecules on these cells. The enhancement of HLA-class I is dependent on infectious virus, as antibody-neutralized MV has no effect on class I expression. In this study, we demonstrate the presence of an HLA- class I-enhancing factor in supernatants from MV-infected cells. The supernatant class I-enhancing factor is not IFN-gamma, IFN-alpha, or TNF-alpha because MV-infected cells did not produce measurable levels of these cytokines as detected by immunoassay or polymerase chain reaction. In contrast, IFN-beta is produced by the infected cells and the supernatant class I-enhancing factor could be entirely neutralized by antibodies to IFN-beta, but not antibodies to IFN-alpha, TNF-alpha, or non-immune sera. Furthermore, preincubation of cells with neutralizing antibodies to IFN-beta prior to infection blocked MV enhancement of HLA-class I completely in the U-105 MG cells and by as much as 74% in the umbilical vein endothelial cells. The results of these experiments provide direct evidence that enhanced HLA-class I expression in MV-infected cells is mediated primarily by IFN-beta.


This article has been cited by other articles:


Home page
J. Immunol.Home page
G. Raghuraman, Y. Geng, and C.-R. Wang
IFN-beta-Mediated Up-Regulation of CD1d in Bacteria-Infected APCs
J. Immunol., December 1, 2006; 177(11): 7841 - 7848.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Tissari, J. Siren, S. Meri, I. Julkunen, and S. Matikainen
IFN-{alpha} Enhances TLR3-Mediated Antiviral Cytokine Expression in Human Endothelial and Epithelial Cells by Up-Regulating TLR3 Expression
J. Immunol., April 1, 2005; 174(7): 4289 - 4294.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Alba, M. C. Puertas, J. Carrillo, R. Planas, R. Ampudia, X. Pastor, F. Bosch, R. Pujol-Borrell, J. Verdaguer, and M. Vives-Pi
IFN{beta} Accelerates Autoimmune Type 1 Diabetes in Nonobese Diabetic Mice and Breaks the Tolerance to {beta} Cells in Nondiabetes-Prone Mice
J. Immunol., December 1, 2004; 173(11): 6667 - 6675.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. A. Kraus, M. J. Raftery, T. Giese, R. Ulrich, R. Zawatzky, S. Hippenstiel, N. Suttorp, D. H. Kruger, and G. Schonrich
Differential Antiviral Response of Endothelial Cells after Infection with Pathogenic and Nonpathogenic Hantaviruses
J. Virol., June 15, 2004; 78(12): 6143 - 6150.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
T. W. Geisbert, L. E. Hensley, T. Larsen, H. A. Young, D. S. Reed, J. B. Geisbert, D. P. Scott, E. Kagan, P. B. Jahrling, and K. J. Davis
Pathogenesis of Ebola Hemorrhagic Fever in Cynomolgus Macaques: Evidence that Dendritic Cells Are Early and Sustained Targets of Infection
Am. J. Pathol., December 1, 2003; 163(6): 2347 - 2370.
[Abstract] [Full Text]


Home page
J. Virol.Home page
P. T. Massa, S. L. Ropka, S. Saha, K. L. Fecenko, and K. L. Beuler
Critical Role for Protein Tyrosine Phosphatase SHP-1 in Controlling Infection of Central Nervous System Glia and Demyelination by Theiler's Murine Encephalomyelitis Virus
J. Virol., July 17, 2002; 76(16): 8335 - 8346.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Servet-Delprat, P.-O. Vidalain, O. Azocar, F. Le Deist, A. Fischer, and C. Rabourdin-Combe
Consequences of Fas-Mediated Human Dendritic Cell Apoptosis Induced by Measles Virus
J. Virol., May 1, 2000; 74(9): 4387 - 4393.
[Abstract] [Full Text]


Home page
Exp. Biol. Med.Home page
G. Herbein and W. A. O'brien
Tumor Necrosis Factor (TNF)-{alpha} and TNF Receptors in Viral Pathogenesis
Experimental Biology and Medicine, March 1, 2000; 223(3): 241 - 257.
[Abstract] [Full Text]


Home page
J. Virol.Home page
P.-O. Vidalain, O. Azocar, B. Lamouille, A. Astier, C. Rabourdin-Combe, and C. Servet-Delprat
Measles Virus Induces Functional TRAIL Production by Human Dendritic Cells
J. Virol., January 1, 2000; 74(1): 556 - 559.
[Abstract] [Full Text]


Home page
J. Virol.Home page
K. H. Noe, C. Cenciarelli, S. A. Moyer, P. A. Rota, and M. L. Shin
Requirements for Measles Virus Induction of RANTES Chemokine in Human Astrocytoma-Derived U373 Cells
J. Virol., April 1, 1999; 73(4): 3117 - 3124.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.